TSE: 3455 - Healthcare & Medical Investment Corporation

Yield per half year: -0.9743%
Dividend yield: +8.70%
Sector: Real Estate

Company Analysis Healthcare & Medical Investment Corporation

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Dividends (8.7%) are higher than the sector average (6.08%).

Disadvantages

  • Price (110500 Β₯) is higher than fair price (67287.07 Β₯)
  • The stock's return over the last year (-14.46%) is lower than the sector average (2.33%).
  • Current debt level 49.91% has increased over 5 years from 47.49%.
  • The company's current efficiency (ROE=5.45%) is lower than the sector average (ROE=8.21%)

Similar companies

Mitsui Fudosan Co., Ltd.

Daiwa House Industry Co.,Ltd.

Mitsubishi Estate Co., Ltd.

Sumitomo Realty & Development Co., Ltd.

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Healthcare & Medical Investment Corporation Real Estate Index
7 days 8.2% 0% 2.8%
90 days 5.4% 2.3% -10.6%
1 year -14.5% 2.3% -7.2%

3455 vs Sector: Healthcare & Medical Investment Corporation has significantly underperformed the "Real Estate" sector by -16.79% over the past year.

3455 vs Market: Healthcare & Medical Investment Corporation has significantly underperformed the market by -7.3% over the past year.

Stable price: 3455 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: 3455 with weekly volatility of -0.2781% over the past year.

3. Summary of the report

3.1. General

P/E: 23.54
P/S: 10

3.2. Revenue

EPS 5853.27
ROE 5.45%
ROA 2.56%
ROIC 0%
Ebitda margin 65.42%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (110500 Β₯) is higher than the fair price (67287.07 Β₯).

Price is higher than fair: The current price (110500 Β₯) is 39.1% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (23.54) is lower than that of the sector as a whole (94.07).

P/E vs Market: The company's P/E (23.54) is lower than that of the market as a whole (135.52).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.28) is lower than that of the sector as a whole (73.45).

P/BV vs Market: The company's P/BV (1.28) is lower than that of the market as a whole (103.8).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (10) is lower than that of the sector as a whole (77.16).

P/S vs Market: The company's P/S indicator (10) is lower than that of the market as a whole (104.68).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (25) is lower than that of the sector as a whole (88.05).

EV/Ebitda vs Market: The company's EV/Ebitda (25) is lower than that of the market as a whole (110.33).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 2.63% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (2.63%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.34%).

5.4. ROE

ROE vs Sector: The company's ROE (5.45%) is lower than that of the sector as a whole (8.21%).

ROE vs Market: The company's ROE (5.45%) is lower than that of the market as a whole (8.34%).

5.5. ROA

ROA vs Sector: The company's ROA (2.56%) is lower than that of the sector as a whole (3.65%).

ROA vs Market: The company's ROA (2.56%) is lower than that of the market as a whole (3.65%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.52%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.77%).

6. Finance

6.1. Assets and debt

Debt level: (49.91%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 47.49% to 49.91%.

Excess of debt: The debt is not covered by net income, percentage 1979.33%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 8.7% is higher than the average for the sector '6.08%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 8.7% has been steadily paid over the past 7 years, DSI=0.86.

Weak dividend growth: The company's dividend yield 8.7% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.

7.3. Payout percentage

Dividend Coverage: Current payments from income (111.29%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Healthcare & Medical Investment Corporation

9.3. Comments